Created in 2004 with an innovative technology of tissues detection in CT scan, Intrasense designs, develops and markets Myrian®, a unique, vendor-neutral software suite for the visualization and advanced processing of multimodal medical images such as MRI, CT scans, PET, X-rays, and more. Developed with leading academic and scientific partners, Myrian® combines and uses all of the various medical images to extract information vital to the patient's care, to evaluate treatment efficiency and to assess drug candidates in oncology and other pathologies. With more than 700 client sites around the world, Myrian® has been certified as a "medical device" in over 40 countries including the United States (FDA), Europe (CE) and Asia. Intrasense SA is listed on the Alternext (FR0011179886 - ALINS).The company employs 60 people, including 25 dedicated in R&D.
Medis medical imaging systems bv. (MEDIS) is a leading provider of software solutions that enable clinicians, technicians and researchers to accurately quantify cardiovascular images. MEDIS' solutions help improve the quality of diagnosis, treatment planning and patient follow-up. They help drive innovations in research and assess the effectiveness of new treatments and devices. MEDIS is a privately owned company, which was founded in 1989 as a spin-off of the Leiden University Medical Center's Laboratory for Clinical and Experimental Image Processing (LKEB). An innovation-driven and customer-oriented company, MEDIS aims to empower medical professionals by providing them with high-quality quantification software. MEDIS complies with international standards and regulations to ensure the safety and effectiveness of its products. MEDIS is an ISO 9001:2000 and ISO 13485:2003 certified company, and it has implemented the Software Engineering Institute's CMMi® model to control its software development process.
Benefit from the most advanced brain imaging techniques.